- Home
- HOTH vs BNOX Comparison
HOTH vs BNOX Comparison
Compare HOTH & BNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- BNOX
- Stock Information
- Founded
- HOTH 2017
- BNOX 1996
- Country
- HOTH United States
- BNOX Australia
- Employees
- HOTH N/A
- BNOX N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- BNOX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HOTH Health Care
- BNOX Health Care
- Exchange
- HOTH Nasdaq
- BNOX Nasdaq
- Market Cap
- HOTH 5.8M
- BNOX 6.3M
- IPO Year
- HOTH 2019
- BNOX 2021
- Fundamental
- Price
- HOTH $0.81
- BNOX $0.29
- Analyst Decision
- HOTH Strong Buy
- BNOX Strong Buy
- Analyst Count
- HOTH 4
- BNOX 1
- Target Price
- HOTH $4.75
- BNOX $8.00
- AVG Volume (30 Days)
- HOTH 1.2M
- BNOX 691.4K
- Earning Date
- HOTH 12-24-2024
- BNOX 01-01-0001
- Dividend Yield
- HOTH N/A
- BNOX N/A
- EPS Growth
- HOTH N/A
- BNOX N/A
- EPS
- HOTH N/A
- BNOX N/A
- Revenue
- HOTH N/A
- BNOX N/A
- Revenue This Year
- HOTH N/A
- BNOX N/A
- Revenue Next Year
- HOTH N/A
- BNOX N/A
- P/E Ratio
- HOTH N/A
- BNOX N/A
- Revenue Growth
- HOTH N/A
- BNOX N/A
- 52 Week Low
- HOTH $0.58
- BNOX $0.18
- 52 Week High
- HOTH $1.73
- BNOX $1.60
- Technical
- Relative Strength Index (RSI)
- HOTH 42.94
- BNOX 47.76
- Support Level
- HOTH $0.82
- BNOX $0.27
- Resistance Level
- HOTH $0.84
- BNOX $0.35
- Average True Range (ATR)
- HOTH 0.04
- BNOX 0.03
- MACD
- HOTH -0.00
- BNOX 0.00
- Stochastic Oscillator
- HOTH 14.50
- BNOX 18.78
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
About BNOX Bionomics Limited American Depository Shares
Bionomics Ltd is a clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.